These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 36781879)
21. Fast and long-lasting immune response to S-trimer COVID-19 vaccine adjuvanted by PIKA. Liu Y; Dai L; Feng X; Gao R; Zhang N; Wang B; Han J; Zou Q; Guo X; Zhu H; Liu J; Qin C; Zhang Y; Bao L; Li M Mol Biomed; 2021; 2(1):29. PubMed ID: 34766005 [TBL] [Abstract][Full Text] [Related]
22. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques. Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002 [TBL] [Abstract][Full Text] [Related]
23. Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle. Royal JM; Simpson CA; McCormick AA; Phillips A; Hume S; Morton J; Shepherd J; Oh Y; Swope K; DeBeauchamp JL; Webby RJ; Cross RW; Borisevich V; Geisbert TW; Demarco JK; Bratcher B; Haydon H; Pogue GP Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835278 [TBL] [Abstract][Full Text] [Related]
24. An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1/2009 influenza vaccines in children 10-17 years of age. Poder A; Simurka P; Li P; Roy-Ghanta S; Vaughn D Vaccine; 2014 Feb; 32(9):1121-9. PubMed ID: 24252703 [TBL] [Abstract][Full Text] [Related]
25. Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice. Maltseva M; Galipeau Y; Renner TM; Deschatelets L; Durocher Y; Akache B; Langlois MA Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679875 [TBL] [Abstract][Full Text] [Related]
26. Longitudinal Follow-Up of the Immunity to SARS-CoV-2 in Health Care Workers in Argentina: Persistence of Humoral Response and Neutralizing Capacity after Sputnik V Vaccination. Castro EF; Acosta J; Moriena L; Rios Medrano M; Tejerina Cibello M; Codino E; Taborda MÁ; Álvarez DE; Cavatorta AL mSphere; 2023 Jun; 8(3):e0066222. PubMed ID: 37070983 [TBL] [Abstract][Full Text] [Related]
27. Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern. Renner TM; Akache B; Stuible M; Rohani N; Cepero-Donates Y; Deschatelets L; Dudani R; Harrison BA; Baardsnes J; Koyuturk I; Hill JJ; Hemraz UD; Régnier S; Lenferink AEG; Durocher Y; McCluskie MJ Front Immunol; 2023; 14():1182556. PubMed ID: 37122746 [TBL] [Abstract][Full Text] [Related]